By Daniel Siegal ( May 20, 2019, 10:47 PM EDT) -- A Connecticut jury on Friday handed Boehringer Ingelheim Pharmaceuticals its first loss in several bellwether trials in a consolidated proceeding over the alleged bleeding risk of its blood thinner Pradaxa, finding the drug caused a man's internal bleeding and awarding him over $500,000 plus punitive damages....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.